BioTelemetry, Inc. (NASDAQ:BEAT) Q4 2019 Earnings Conference Call - Final Transcript
Feb 26, 2020 • 05:00 pm ET
Joseph H. Capper
above expectations in these three areas, we are most of the way there. Any additional contributions from the ADEA business or collaborations we may implement throughout the year will further bolster the performance of this division. Therefore, we are well positioned to achieve our double-digit revenue growth objective, even with more modest contributions from the other businesses. Add to this, the possibility of additional investments and acquisitions in various parts of the enterprise. As mentioned, our business development pipeline is active, and we were able to execute on it, given our strong balance sheet and significant free cash generation. As Heather mentioned, we recently added even more flexibility and capacity with the establishment of a new debt facility.
Given our dynamic capabilities, BioTelemetry is able to capitalize both in the short term and long term, as our technology and platform are uniquely suited to address large and developing opportunities. For these reasons, we are extremely excited about our future prospects and expect 2020 to be another record setting year.
I would again like to sincerely thank those of you who helped deliver our 30th consecutive growth quarter, and a special thank you goes to so many people in the Company who went well above and beyond the call in the face of the previously-mentioned challenges.
With that, we'll now pause and open the call to your questions. Operator, we're ready for our first question.